Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0272727272727273 0.0272727272727273 0.0545454545454545 0.0818181818181818
Stock impact report

FDA OKs Foundation Med's CDx cancer test; shares up 2% after hours [Seeking Alpha]

FOUNDATION MEDICINE (FMI) 
Last foundation medicine earnings: 5/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.foundationmedicine.com
Company Research Source: Seeking Alpha
FDA OKs Foundation Med's CDx cancer test; shares up 2% after hoursThe FDAapproves the FoundationOne CDx, a next-gen sequencing (NGS)-based in vitro diagnostic test that can detect mutations in 324 genes and two genomic signatures in any solid tumor type.CMS will cover reimbursement for Medicare beneficiaries with advanced cancers who have not been previously tested using the same NGS technology and who continue to seek further cancer therapy.Developer Foundation Medicine (NASDAQ:FMI) is up2% after hours on light volume.See all stocks on the move » Show less Read more
Impact Snapshot
Event Time:
FMI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for FMI alerts
Opt-in for
FMI alerts

from News Quantified
Opt-in for
FMI alerts

from News Quantified